Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy: Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems
E Pessina, Luca Degli Esposti, Francesco Lapi, Aldo Maggioni, C Uslenghi (2016). Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy: Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems. , 19(7), DOI: https://doi.org/10.1016/j.jval.2016.09.1821.
